Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.12
08.02.21
€5.00
08.02.22
14.10%
22.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€36.75
25.01.21
€50.00
25.01.22
-12.24%
08.02.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
23.01.21
€30.00
23.01.22
-67.09%
24.01.22

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35.75
23.01.21
-
23.01.22
-73.67%
24.01.22

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€12.90
17.10.20
-
04.11.21
-29.07%
24.03.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.45
23.09.20
-
04.11.21
-47.51%
15.07.21

Probably not worthwhile Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
21.09.20
-
28.09.20
40.54%
28.09.20

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
19.09.20
-
29.09.20
72.97%
29.09.20

High risks for its business
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
19.09.20
-
23.09.20
34.46%
23.09.20

Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€4.94
06.09.20
-
19.09.20
49.80%
19.09.20

High risks for its business
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.27
03.09.20
-
03.09.20
-
03.09.20

High risks for its business
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.65
22.08.20
-
03.09.20
-11.28%
03.09.20

High risks for its business
buy
Sintx Technologies Inc.

Start price
Target price
Perf. (%)
€214.00
20.06.20
-
23.06.20
-43.93%
23.06.20

buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€2.48
14.06.20
€5.00
04.11.21
-8.87%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
EOS Imaging

Start price
Target price
Perf. (%)
€1.39
14.11.19
€2.80
04.11.21
74.82%
05.11.21

Could be worthwhile Investment >10% per year
buy
Sintx Technologies Inc.

Start price
Target price
Perf. (%)
€517.93
26.05.19
€676.50
30.10.19
-76.83%
30.10.19

buy
Biom Up SA

Start price
Target price
Perf. (%)
?2.38
13.05.19
€3.90
04.11.19
0.00%
04.11.19

buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€5.32
07.05.19
€9.02
11.06.19
22.99%
11.06.19

buy
Iridex Corp.

Start price
Target price
Perf. (%)
€4.64
21.04.19
€8.12
30.10.19
-65.06%
30.10.19

buy
Fulgent Genetics Inc

Start price
Target price
Perf. (%)
€6.06
10.04.19
€12.18
15.11.19
70.01%
15.11.19

buy
Diversicare Healthcare Services Inc

Start price
Target price
Perf. (%)
?3.73
17.03.19
€5.86
22.04.19
-11.62%
22.04.19